Komen Research Grant Opportunities: Career Transition Awards & Career Catalyst Research Grants

Posted in DEI Funding Opportunities

Two mechanisms from Susan G. Komen available: one for postdoctoral fellows and one for early-career faculty.  June 26 deadline for institutions to indicate to Komen that they will have applicants. Interested candidates email Dr. Becca Riggins (rb7@georgetown.edu (new window)) to indicate that you plan to apply.

Both grant mechanisms are limited submission opportunities: 

  • Each institution may submit up to two nominees
  • At least one of the two nominees identifies as someone from groups shown to be historically minoritized and marginalized in biomedical research from National Science Foundation data, including Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians and other Pacific Islanders, and individuals with disabilities, as well as individuals from disadvantaged backgrounds. Research projects must be hypothesis-driven, breast cancer-focused studies. 

Brief descriptions are below, but please refer to the full Letter of Intent (LOI) announcements attached to this email for eligibility requirements, deadlines and LOI submission instructions: 

  • Career Transition Awards (CTA) aims to help outstanding senior postdoctoral and clinical research fellows launch their competitive, independent breast cancer research careers. The CTA provides up to five years of funding in two phases: Phase 1 supports the final years of their postdoctoral research and Phase 2 supports their independent research as they begin their careers as tenure-track investigators.  
  • Career Catalyst Research (CCR) grants foster promising breast cancer researchers who are in the early stages of their faculty careers by providing support for up to three years of “protected time” for research career development under the guidance of a Mentor Committee. We seek to support those who will emerge as the next key leaders in the fight against breast cancer.  

Letter of Intent (LOI) Announcement: June 12, 2024
Institution Opt in Deadline: June 26, 2024
Letter of Intent Due: August 7, 2024, by 1 p.m., Eastern Time
Letter of Intent Decision: August 21, 2024
Application Due: October 9, 2024, by 1 p.m., Eastern Time
Award Notification: On or around April 15, 2025

Applicants/Primary Investigators (PIs) may request funding of up to $150,000 per year (combined direct and indirect costs) for up to three years ($450,000).